Publicações

Se você estiver utilizando o navegador Google Chrome, recomendamos a instalação das extensões: Botão do Google AcadêmicoGoogle TradutorAdBlock, para facilitar sua pesquisa por artigos científicos.

Publicações Técnicas da ABENFO-MS

Sessão com visualização e download disponível apenas para associados.
*Se você perdeu seu acesso, solicite pelo formulário de contato.

  • Classificação de Risco em Obstetrícia
  • Projeto Modelo de Normatização da Assistência de Enfermagem Obstétrica
  • Partograma
  • Projeto Modelo de Visita Monitorada da Gestante à Maternidade

Trabalhos de Conclusão de Curso (Estado de MS)

Sessão com visualização e download disponível apenas para associados.
*Se você perdeu seu acesso, solicite pelo formulário de contato.

Materiais Técnicos

Evidências Científicas

 

 

 

  • Hipertensão
    • Duley L. The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 2009; 33(3):130–137.
    • Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet, 2010; 21;376(9741):631–44.
    • Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-22.
    • Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet, 2006; 367(9516):1066–1074.
    • Campbell OM, Graham WJ; Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet, 2006, 368 (9543): 1284–1299.
    • Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG; HYPITAT study group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374(9694):979-88.
    • Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200(5):481.e1-7.
    • World Health Organization. WHO Recommendations for Prevention and Treatment of pre-eclampsia and eclampsia. Geneva, Switzerland, 2011.
    • Churchill D, Duley L. Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Review. Cochrane Database Syst Rev. 2006;(3):CD003106.
    • Amorim MM, Santos LC, Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999; 180 (5): 1283-8.
    • Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Review. Cochrane Database Syst Rev. 2006; (3):CD004454.
    • Noronha-Neto C, Souza ASR, Amorim MMR. Tratamento da pré-eclâmpsia baseado em evidências. Rev. Bras. Ginecol. Obstet. 2010; 32 (9): 459-468.
    • Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Review. 2006; Cochrane Database Syst Rev.(3):CD001449.
    • Seal SL, Ghosh D, Kamilya G, Mukherji J, Hazra A, Garain P. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol. 2012; 206(6): 484.e1-7.
    • Amorim MMR, Souza ASR, Katz L, Noronha-Neto C. Planned caesarean section versus planned vaginal delivery for severe preeclampsia. Cochrane Protocol. 2011. Cochrane Database Syst Rev. (11): CD009430.
    • ACOG Committee on Practice Bulletins–Obstetrics.ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002; 99(1):159-67.
    • Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004; 31(4): 807-33.
    • World Health Organization. WHO Recommendations for Induction of Labour. Geneve, Switzerland, 2010.
    • Amorim MM, Katz L, Coutinho I, Souza AS, Scavuzzi A, Santos Filho O, et al. Risk factors for cesarean section in patients with severe preeclampsia. Int J Gynaecol Obstet. 2009;107 Suppl 2:462.
    • Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D; Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002; 359(9321):1877-90.
    • Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010; (11): CD000025.
    • Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol. 2004; 190(6):1520-6.
    • Norwitz ER. Eclampsia. In: Uptodate. Topic 1662 Version 12.0, 2012.
    • The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995; 345(8963):1455-63.
    • Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Review. Cochrane Database Syst Rev. 2010; (10):CD000128.
    • Duley L, Henderson-Smart DJ, Walker GJ, Chou D.Magnesium sulphate versus diazepam for eclampsia.Cochrane Review. Cochrane Database Syst Rev. 2010; (12): CD000127.
    • Duley L, Gülmezoglu AM, Chou D.Magnesium sulphate versus lytic cocktail for eclampsia.Cochrane Review. Cochrane Database Syst Rev. 2010;(9):CD002960.
    • Amorim MMR, Katz L, Souza ASR. Hipertensão e Gravidez. In: Santos LC, Mendonça VG, Pôrto AMF, Guerra GVQL, Coêlho ICCAN. Gestação de Alto Risco Baseada em Evidências (IMIP). MedBook, Rio de Janeiro, 2011.
    • Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005; 330 (7491): 565.
    • Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007;109(1):168-80.
    • Karumanchi SA, Lim KH, August P. Pathogenesis of preeclampsia. In: Uptodate. Topic 6760 Version 9.0, 2012.
    • Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.Cochrane Review. Cochrane Database Syst Rev. 2010;(8):CD001059.
    • Duley L, Henderson-Smart DJ, Meher S, King JF.Antiplatelet agents for preventing pre-eclampsia and its complications.Cochrane Review. Cochrane Database Syst Rev. 2007;(2):CD004659.
    • Amorim MMR, Souza ASR. Prevenção da pré-eclâmpsia baseada em evidências. Femina. 2009; 37(1): 47-52.
    • Rumbold A, Duley L, Crowther CA, Haslam RR.Antioxidants for preventing pre-eclampsia. Cochrane Review. Cochrane Database Syst Rev. 2008;(1):CD004227.
    • Prado AD, Piovesan DM, Staub HL, Horta BL. Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol. 2010; 116(6): 1433-33.
    • Lockwood CJ, Schur PH. Obstetrical manifestations of the antiphospholipid syndrome. In: Uptodate. Topic 6813 Version 9.0, 2012.
    • Di Prima FA, Valenti O, Hyseni E, Giorgio E, Faraci M, Renda E, De Domenico R, Monte S. Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med. 2011;5(2):41-53.
    • Lockwood CJ, Schur PH. Management of pregnant women with antiphospholipid antibodies or the antiphospholipid syndrome. In: Uptodate. Topic 6816 Version 7.0, 2012.

 

Vídeos

Legislações (Enfermagem Obstétrica)